The independent source for health policy research, polling, and news.
121-140 of 396 results
Former President Donald Trump, who鈥檚 running for another term in the White House, recently blamed drug shortages on his successor, President Joe Biden. Our findings don鈥檛 align with Trump鈥檚 claims; by some measures, drug shortages increased more on Trump鈥檚 watch than on Biden鈥檚.
Software sifts through millions of medical records to match patients with similar diagnoses and characteristics and then predicts what kind of care an individual will need and for how long. New federal rules will ensure human experts are part of the process.
Though never framed as a marquee issue, the topic of health care crept into the chaotic seven-way faceoff throughout the evening, highlighting Republican culture-war themes.
Medicare and Medicaid shouldn鈥檛 be affected, but confusion can be expected.
The White House said the Consumer Financial Protection Bureau will develop new regulations that would prevent unpaid medical bills from being counted on credit reports.
Congress appears to be careening toward a government shutdown, as a small band of House conservatives vow to block any funding for the fiscal year that begins Oct. 1 unless they win deeper cuts to health and other domestic programs. Meanwhile, former President Donald Trump continues to roil the GOP presidential primary field, this time with comments about abortion. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Tami Luhby of CNN join 51视频 Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
Before covid-19, hepatitis C held the distinction of claiming more American lives each year than any other infectious disease 鈥 that鈥檚 despite the marketing of several relatively affordable, highly effective treatments.
The Biden administration says a recently proposed minimum staffing standard would help ensure quality care, but nursing home leaders predict many rural facilities would struggle to meet it.
Congress returns from its summer recess with a long list of tasks and only a few work days to get them done. On top of the annual spending bills needed to keep the government operating, on the list are bills to renew the global HIV/AIDS program, PEPFAR, and the community health centers program. Meanwhile, over the recess, the Biden administration released the names of the first 10 drugs selected for the Medicare price negotiation program.
Studies suggest official numbers vastly underestimate heat-related injuries and illness on the job. To institute protections, the government must calculate their cost 鈥 and the cost of inaction.
The proposal would require major hiring at the most sparsely staffed homes. But the proposal is already badly received by the nursing home industry, which claims it can鈥檛 boost wages enough to attract workers.
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
Research commissioned by the Centers for Medicare & Medicaid Services analyzed only staffing levels below what experts have previously called ideal. Patient advocates have been pushing for more staff to improve care.
A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market 鈥 rejecting a lower court鈥檚 decision to effectively cancel the drug鈥檚 FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court鈥檚 ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Politico, and Shefali Luthra of The 19th join 51视频 Health News鈥 chief Washington correspondent, Julie Rovner, to discuss these issues and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
Federal officials are trying to clamp down on private arrangements among some hospitals to pay themselves back for the Medicaid taxes they鈥檝e paid. State health officials and the influential hospital industry argue that regulators have no jurisdiction over the agreements.
A Biden administration proposal would help standardize the data on prices that hospitals provide to patients, increase its usefulness to consumers, and boost enforcement. Previous rules gave hospitals too many loopholes.
FDA Commissioner Robert Califf has called misinformation one of the deadliest killers in the United States. As the FDA tries to fight that scourge, it sometimes stumbles.
House Republican legislation promises more health insurance options but fewer protections, even as the Biden administration seeks to rein in short-term plans, which were expanded in the Trump era.
President Biden made good on a campaign promise this week with a proposal that would limit short-term health insurance plans that boast low premiums but also few benefits. Meanwhile, the Supreme Court鈥檚 decision to outlaw affirmative action programs could set back efforts to diversify the nation鈥檚 medical workforce. Alice Miranda Ollstein of Politico, Amy Goldstein of the Washington Post, and Rachel Cohrs of Stat News join 51视频 Health News鈥 chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews 51视频 Health News鈥 Bram Sable-Smith, who reported the latest 51视频 Health News-NPR 鈥淏ill of the Month鈥 about how a hospital couldn鈥檛 track down a patient, but a debt collector could.
Citing the recent debt ceiling deal, the CDC is trimming its funding to child vaccination programs that focus on communities vulnerable to disease outbreaks. The cuts come despite data showing the percentage of children getting vaccinated has dropped in recent years.
漏 2026 51视频